StockStory Taps Alignment Healthcare (ALHC) as Buy, Warns on Procter & Gamble (PG), PACCAR (PCAR) Valuations

StockStory designated Alignment Healthcare (NASDAQ:ALHC) a buy and cautioned against Procter & Gamble (NYSE:PG) and PACCAR (NASDAQ:PCAR) in a June 2, 2026 note, focusing on cash-flow efficiency and valuation gaps. The research firm highlighted that strong free cash flow alone does not make a stock attractive if multiples are stretched. Procter & Gamble, with a trailing 12-month free cash flow margin of 18.1%, trades at 20.8 times forward earnings. PACCAR, posting a 13.1% margin, carries an 18.5 times forward price-to-earnings ratio. StockStory argued that these valuations raise caution flags despite solid cash generation. Conversely, Alignment Healthcare, with a 5.3% free cash flow margin, trades at 16.8 times forward enterprise value to EBITDA. The firm views the Medicare Advantage provider’s valuation as more compelling. Alignment Healthcare shares closed at $13.25, while Procter & Gamble ended at $140.42 and PACCAR at $109.48.